除资本端积极动作外，公司主营业务亦传来进展。公司主运营的2026年度北京普惠健康保参保人数已突 破450万，作为连续五年担任该项目主运营平台的企业，医渡科技凭借专业的运营服务与技术赋能，持 续助力首都多层次医疗保障体系建设，进一步彰显了其业务实力与市场认可度。 1月28日，医渡科技(02158)再度发布股份回购公告，宣布当日以每股约6港元的价格回购20.4万股，耗资 约123万港元。至此，公司已连续三个交易日密集实施回购操作，合计回购约70.9万股，累计耗资超420 万港元，持续以真金白银释放对公司内在价值的认可及长远发展的坚定信心。 此前消息显示，医渡科技创始人、董事长宫如璟近期受邀出席2026冬季达沃斯论坛，期间诺华基金会、 文莱卫生部与公司旗下EVYD公司三方合作消息宣布，将联合实施数智驱动的心血管疾病防控项目 CARDIO4Cities，进一步拓展国际合作版图。与此同时，行业权威榜单《2025医疗大数据企业排行榜》 正式揭晓，医渡科技凭借深厚的技术积淀、成熟的产品体系与丰富的行业落地经验，连续第七年斩获榜 首，持续领跑医疗大数据赛道。 ...

智通财经APP获悉，1月28日，医渡科技(02158)再度发布股份回购公告，宣布当日以每股约6港元的价格 回购20.4万股，耗资约123万港元。至此，公司已连续三个交易日密集实施回购操作，合计回购约70.9万 股，累计耗资超420万港元，持续以真金白银释放对公司内在价值的认可及长远发展的坚定信心。 除资本端积极动作外，公司主营业务亦传来进展。公司主运营的2026年度北京普惠健康保参保人数已突 破450万，作为连续五年担任该项目主运营平台的企业，医渡科技凭借专业的运营服务与技术赋能，持 续助力首都多层次医疗保障体系建设，进一步彰显了其业务实力与市场认可度。 此前消息显示，医渡科技创始人、董事长宫如璟近期受邀出席2026冬季达沃斯论坛，期间诺华基金会、 文莱卫生部与公司旗下EVYD公司三方合作消息宣布，将联合实施数智驱动的心血管疾病防控项目 CARDIO4Cities，进一步拓展国际合作版图。与此同时，行业权威榜单《2025医疗大数据企业排行榜》 正式揭晓，医渡科技凭借深厚的技术积淀、成熟的产品体系与丰富的行业落地经验，连续第七年斩获榜 首，持续领跑医疗大数据赛道。 ...

1月27日，医渡科技(02158)发布公告显示，公司当日以每股约6港元的价格回购37.86万股，回购金额近 230万港元，已连续两日回购，合计回购50.5万股，累计回购金额超300万港元。 与此同时，行业权威榜单的发布进一步印证了医渡科技的行业地位。《2025 医疗大数据企业排行榜》 正式揭晓，医渡科技凭借深厚的技术积淀、成熟的产品体系与丰富的行业落地经验，连续第七年斩获榜 首，持续领跑医疗大数据赛道。 消息面上，医渡科技创始人、董事长宫如璟近日受邀出席2026冬季达沃斯论坛，参与多场高级别行业对 话及闭门会议，并密集会见了全球政商学界领袖与合作伙伴。论坛上，诺华公司董事会主席Giovanni Caforio博士宣布一项重要合作：诺华基金会、文莱卫生部、医渡科技旗下EVYD公司将联合实施数智驱 动的心血管疾病防控项目——CARDIO4Cities。 ...

智通财经APP获悉，1月27日，医渡科技(02158)发布公告显示，公司当日以每股约6港元的价格回购 37.86万股，回购金额近230万港元，已连续两日回购，合计回购50.5万股，累计回购金额超300万港元。 与此同时，行业权威榜单的发布进一步印证了医渡科技的行业地位。《2025 医疗大数据企业排行榜》 正式揭晓，医渡科技凭借深厚的技术积淀、成熟的产品体系与丰富的行业落地经验，连续第七年斩获榜 首，持续领跑医疗大数据赛道。 消息面上，医渡科技创始人、董事长宫如璟近日受邀出席2026冬季达沃斯论坛，参与多场高级别行业对 话及闭门会议，并密集会见了全球政商学界领袖与合作伙伴。论坛上，诺华公司董事会主席Giovanni Caforio博士宣布一项重要合作：诺华基金会、文莱卫生部、医渡科技旗下EVYD公司将联合实施数智驱 动的心血管疾病防控项目——CARDIO4Cities。 ...

Group 1: Industrial Policy and Technological Advancements - The Ministry of Industry and Information Technology has issued a revised management approach for public service platforms in industrial technology, effective from December 5, 2025, emphasizing the need for service platforms to enhance their capabilities and optimize service quality [1][1] - Inner Mongolia Geological and Mineral Group has developed the first specialized dataset for mineral exploration using AI technology, marking a significant advancement in intelligent geological exploration [1][5] Group 2: Food Safety and Digital Innovation - Heilongjiang Province has implemented digital food labels for 105 products, enhancing consumer information accessibility and promoting food safety through interactive features [2][5] - The initiative aims to improve consumer awareness and support food enterprises through increased promotion and technical guidance [2][5] Group 3: Meteorological Data and Flood Risk Management - The Henan Meteorological Bureau has developed a dataset for typical flood events in the Yellow River basin, which has passed the national approval process, enhancing flood risk prediction and management capabilities [3][6] - This dataset integrates various data sources to improve the accuracy of flood risk assessments and extend the forecasting period [3][6] Group 4: Social Science and AI Integration - A new AI model for social sciences has been launched in Hubei, featuring a dedicated interactive robot and a team of digital social science experts, marking a significant step in integrating AI with social research [4][7] - The AI platform is designed to support data sharing and collaborative research, ensuring rigorous academic standards [4][7] Group 5: Healthcare Data Management - The establishment of the first provincial-level big data center for healthcare in Hainan aims to break down data barriers among healthcare, insurance, and pharmaceutical sectors, facilitating better service delivery [5][7] - This center is expected to enhance the efficiency of healthcare processes and support regulatory compliance in drug safety and medical practices [5][7]

Core Viewpoint - Guoxin Health is actively collaborating with insurance brokerage firms, health management service providers, and medical service institutions to explore a data-driven full-chain service model for health insurance, covering product design, marketing, underwriting, claims, and risk control [2] Group 1: Collaboration and Innovation - The company has established deep cooperative relationships with several domestic insurance companies to promote the implementation of innovative health insurance service models [2] - Guoxin Health is involved in projects such as the operation of public data authorization in Hangzhou and the personal medical insurance data authorization query in Pingxiang, Jiangxi, to enhance data compliance and operational practices [2] Group 2: Data Integration and Development - Guoxin Health has jointly established a company with Hubei Data Group to operate health medical big data in Central China, aiming to integrate and utilize health medical data resources within Hubei Province [2] - The newly formed company serves as a pilot for public data authorization operations in the "Three Medical" fields, facilitating the development and utilization of health medical data resources [2]

Core Insights - The construction of a national-level trusted data space for the pharmaceutical industry will follow three main strategies: government-enterprise co-management, pilot projects in subspaces, and a whitelist approach for gradual implementation [1][2] Group 1: Data Governance in Pharmaceutical Industry - The trusted data space is based on the drug traceability platform launched in 2023, which integrates data across the entire chain of drug production, distribution, and usage [1] - The focus will initially be on mature areas such as biological products, medical devices, and anesthetic drugs, with steady progress being made in these areas [1] Group 2: AI and Healthcare - Key breakthrough areas for AI in healthcare include innovative drug development, intelligent health management, and medical diagnostic assistance [1] - The potential for AI to enhance health management services and reduce misdiagnosis rates is significant, facilitated by the integration of health data [1] Group 3: Collaboration with Guizhou - The company anticipates that the Digital Expo will play a role in policy guidance, standard setting, and ecosystem collaboration within the healthcare big data sector [2] - Future collaboration with Guizhou will focus on integrating industry data spaces with urban data spaces and implementing a personal health account system [2]